EP3727423
MEÐFERÐ VIÐ EFNASKIPTASJÚKDÓMUM MEÐ AFBRIGÐUM AF FGF21
:
EP einkaleyfi í gildi á Íslandi:
21.12.2018:
22.5.2024:
18842846.0
:
8.7.2024:
15.9.2024
:
20.12.2038:
20.12.2025:
31.12.2025
:
TREATMENT OF METABOLIC DISORDERS WITH FGF21 VARIANTS
21.12.2018
22.5.2024
8.7.2024
15.9.2024
20.12.2025
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
GOLDFINE, Allison:
Cambridge, Massachusetts 02139, US
:
YI, Byungdoo Alexander:
Cambridge, Massachusetts 02139, US
:
G.H. Sigurgeirsson ehf.:
Borgartúni 26, 105, Reykjavík,
:
201762609489 P:
22.12.2017:
US
:
IB2018060538:
21.12.2018
:
A61K 38/18, A61K 45/06, A61P 3/06, A61P 3/04, A61P 9/10, A61P 5/50, A61P 9/12
: 7
: 10.12.2024
: 20.12.2025
: G.H. Sigurgeirsson ehf.